Pfizer/BioNTech say updated Covid-19 booster generates 'substantially higher' protection against Omicron subvariants than original vaccine
Pfizer and BioNTech are still conducting larger clinical trials of the updated boosters.
Stay updated with breaking news from Iontech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer and BioNTech are still conducting larger clinical trials of the updated boosters.
Germany’s chancellor has announced limited use for the BioNTech shot in mainland China for foreign residents, but he’s hopeful approval can be expanded.
When someone gets any vaccine, it can take a few weeks to build up immunity and generate its full protection.
The inoculation could simplify immunisation practices and potentially lead to better vaccine uptake for both diseases, say officials
U.S. drugmaker Pfizer Inc and its German partner BioNTech SE have started an early-stage study to evaluate a combination vaccine targeting COVID-19 and influenza, the companies said on Thursday.